Cargando...
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
KRAS mutation is a well‐known marker for poor response to targeted treatment and patient prognosis in microsatellite stable (MSS) colorectal cancer (CRC). However, variation in clinical outcomes among patients wild‐type for KRAS underlines that this is not a homogeneous population. Here, we evaluate...
Guardado en:
| Publicado en: | Int J Cancer |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587976/ https://ncbi.nlm.nih.gov/pubmed/30121958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31809 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|